174 related articles for article (PubMed ID: 101464)
1. Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity.
Lieberman MM
Infect Immun; 1978 Jul; 21(1):76-86. PubMed ID: 101464
[TBL] [Abstract][Full Text] [Related]
2. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.
Lieberman MM; McKissock DC; Wright GL
Infect Immun; 1979 Feb; 23(2):509-21. PubMed ID: 106013
[TBL] [Abstract][Full Text] [Related]
3. Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa.
Gonggrijp R; Mullers WJ; van Boven CP
Infect Immun; 1981 Jul; 33(1):178-85. PubMed ID: 6167518
[TBL] [Abstract][Full Text] [Related]
4. Ribonuclease-sensitive ribosomal vaccines.
Gonggrijp R; Antonissen AC; van den Bosch JF; van Boven CP
Antonie Van Leeuwenhoek; 1984; 50(5-6):763-74. PubMed ID: 6084981
[TBL] [Abstract][Full Text] [Related]
5. Ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.
Gonggrijp R; Mullers WJ; Lemmens PJ; van Boven CP
Infect Immun; 1980 Jan; 27(1):204-10. PubMed ID: 6153637
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. I. Preparation of the protective dialyzable factor from the ribosomal fraction by the freeze-thaw procedure.
Kita E; Matsuura H; Masuda S; Tomihata S; Kashiba S
Microbiol Immunol; 1983; 27(1):7-24. PubMed ID: 6346023
[TBL] [Abstract][Full Text] [Related]
7. Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains.
Lieberman MM; Wright GL; Wolcott KM; McKissock-Desoto DC
Infect Immun; 1980 Aug; 29(2):489-93. PubMed ID: 6783532
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa antigens as potential vaccines.
Stanislavsky ES; Lam JS
FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
[TBL] [Abstract][Full Text] [Related]
9. Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice.
Lieberman MM; Ayala E
J Immunol; 1983 Jul; 131(1):1-3. PubMed ID: 6408166
[No Abstract] [Full Text] [Related]
10. Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis.
Youmans AS; Youmans GP
J Bacteriol; 1966 Jun; 91(6):2146-54. PubMed ID: 4957610
[TBL] [Abstract][Full Text] [Related]
11. Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis.
Johnson W
Infect Immun; 1972 Jun; 5(6):947-52. PubMed ID: 4564407
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa ribosomal vaccine. A comparison of the immunogenicity of vaccines from two different serotypes.
Lieberman MM
Antibiot Chemother (1971); 1989; 42():193-202. PubMed ID: 2512837
[No Abstract] [Full Text] [Related]
13. Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.
Venneman MR; Bigley NJ
J Bacteriol; 1969 Oct; 100(1):140-8. PubMed ID: 4898982
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ribosomal preparations from Pseudomonas aeruginosa to protect against intravenous Pseudomonas challenge in mice.
Smith RL; Wysocki JA; Bruun JN; De Courcy SJ; Blakemore WS; Mudd S
J Reticuloendothel Soc; 1974 Jan; 15(1):22-30. PubMed ID: 4204145
[No Abstract] [Full Text] [Related]
15. Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa.
Mates A; Zand P
J Hyg (Lond); 1974 Aug; 73(1):75-84. PubMed ID: 4213979
[TBL] [Abstract][Full Text] [Related]
16. [Cell-free Pseudomonas vaccine: its immunochemical characteristics and immunogenicity].
Bandman OA; Edvabnaia LS; Bulk VF; Zhvanetskaia MI; Mashilova GM
Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):44-7. PubMed ID: 3124416
[TBL] [Abstract][Full Text] [Related]
17. Active and passive immunization with Pseudomonas aeruginosa ribosomal vaccines and antisera in the burned rat model.
Lieberman MM; Walker HL; Ayala E; Chapa I
J Surg Res; 1986 Feb; 40(2):138-44. PubMed ID: 3080639
[TBL] [Abstract][Full Text] [Related]
18. A new polyvalent Pseudomonas vaccine.
Miler JM; Spilsbury JF; Jones RJ; Roe EA; Lowbury EJ
J Med Microbiol; 1977 Feb; 10(1):19-27. PubMed ID: 402473
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial immunity induced by ribosomal vaccines.
Winston SH; Berry LJ
J Reticuloendothel Soc; 1970 Jul; 8(1):13-24. PubMed ID: 4988339
[No Abstract] [Full Text] [Related]
20. Protective mechanism of the immune response to a ribosomal vaccine from Pseudomonas aeruginosa. I. In vivo protection studies in compromised animal models.
Lieberman MM; Frank WJ
J Surg Res; 1988 Mar; 44(3):242-50. PubMed ID: 3125388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
